THE SIGNIFICANCE OF FUNCTIONAL AND ETIOLOGICAL DIAGNOSTIC FOR TREATMENT STRATEGY DECISION IN PATIENTS WITH DILATED CARDIOMYOPATHY

THE SIGNIFICANCE OF FUNCTIONAL AND ETIOLOGICAL DIAGNOSTIC FOR TREATMENT STRATEGY DECISION IN PATIENTS WITH DILATED CARDIOMYOPATHY

Bibliographic Details
Main Author:	Yu. V. Frolova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2014-05-01
Series:	Российский кардиологический журнал
Subjects:	dilated cardiomyopathy (dcm) heart failure reverse remodeling of the heart endomyocardial biopsy cardioverter-defibrillator (icd) resynchronization therapy (crt-d)
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/65

Similar Items

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
by: Thomas Beiert, et al.
Published: (2018-04-01)

Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)
by: Laura Keil, et al.
Published: (2024-02-01)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
by: Fuwei Liu, et al.
Published: (2023-07-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics)
by: O. V. Blagova, et al.
Published: (2015-09-01)

Devices in Heart Failure Patients—Who Benefits From ICD and CRT?
by: Alexander Breitenstein, et al.
Published: (2019-08-01)

Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy
by: Yu Deng, et al.
Published: (2022-04-01)

Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-07-01)

Can right ventricular endomyocardial biopsy predict left ventricular fibrosis beforehand in dilated cardiomyopathy?
by: Kisaki Amemiya, et al.
Published: (2024-04-01)

Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
by: Mohammed Samy, et al.
Published: (2023-11-01)

Improved outcomes of cardiac resynchronization therapy with a defibrillator in systolic heart failure: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2024-02-01)

Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy
by: Edoardo Bertero, et al.
Published: (2023-08-01)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
by: Carles Díez-López, et al.
Published: (2022-01-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment)
by: O. V. Blagova, et al.
Published: (2015-09-01)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
by: Florian Blaschke, et al.
Published: (2021-08-01)

Endocrine abnormalities in dilated cardiomyopathy
by: Ankit Jain, et al.
Published: (2015-01-01)

A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches
by: Vivek Sarohi, et al.
Published: (2022-06-01)

Application of left ventricular endomyocardial biopsy in the diagnosis of mitochondrial cardiomyopathy: a case report
by: Chuangsen Fang, et al.
Published: (2023-07-01)

MULTISPIRAL COMPUTED TOMOGRAPHY VERSUS MYOCARDIAL BIOPSY IN DIAGNOSTICS OF YOCARDITIS AND PROGNOSIS EVALUATION OF DILATION CARDIOMYOPATHY SYNDROME
by: I. N. Alieva, et al.
Published: (2017-02-01)

Current status of the ICD in nonischemic cardiomyopathy
by: Venkatakrishnan Ramakumar, et al.
Published: (2018-01-01)

Persistent improvement of ejection fraction in patients with a cardiac resynchronisation therapy defibrillator correlates with fewer appropriate ICD interventions and lower mortality
by: Beat Schaer, et al.
Published: (2016-03-01)

Variation in Lead Impedance according to Pacemaker Analyzing Systems
by: Hiroshi Ichiyanagi, et al.
Published: (2010-01-01)

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
by: Marcello Disertori, et al.
Published: (2017-10-01)

Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators
by: Valeria Rella, et al.
Published: (2020-04-01)

Long‐term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction
by: Petr Kuchynka, et al.
Published: (2024-04-01)

Early Use of Cardiac Resynchronization Therapy to Accelerate Symptomatic Relief and Complete Left Ventricular Function Recovery in Peripartum Cardiomyopathy
by: Elizabeth Richard, et al.
Published: (2019-06-01)

The inflammatory spectrum of cardiomyopathies
by: Nicolas Musigk, et al.
Published: (2024-02-01)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
by: Yisachar Greenberg, et al.
Published: (2005-04-01)

Inflammation-Related Biomarkers Are Associated with Heart Failure Severity and Poor Clinical Outcomes in Patients with Non-Ischemic Dilated Cardiomyopathy
by: Ieva Kažukauskienė, et al.
Published: (2021-09-01)

ICD Outcome in Pediatric Cardiomyopathies
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
by: Mohammad Reza Dehghani, et al.
Published: (2006-01-01)

Endomyocardial Biopsy in Pediatric Myocarditis and Dilated Cardiomyopathy: A Tool in Search for a Role
by: Mara Pilati, et al.
Published: (2022-01-01)

Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy
by: Tomoya Ishiguro, et al.
Published: (2021-02-01)

Assessment of cardiac dyssynchrony in Nigerian patients with dilated cardiomyopathy
by: Eme Offiah, et al.
Published: (2016-01-01)

Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry
by: Paul F. Kantor, et al.
Published: (2024-01-01)

Dilated cardiomyopathy associated with NRAP gene: a case series
by: Abdellh A. Names, et al.
Published: (2023-06-01)

Cardiac Resynchronization Therapy: Who Benefits?
by: Jason S. Chinitz, et al.
Published: (2014-04-01)

Case Report: A novel desmoplakin mutation in a taiwanese woman with familial dilated cardiomyopathy that necessitated heart transplantation
by: Yi-Han Chang, et al.
Published: (2022-09-01)

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts
by: Camila Iansen Irion, et al.
Published: (2020-08-01)

Hybrid implantation of Cardiac resynchronization therapy device
by: Alexander Edo Tondas, et al.
Published: (2013-06-01)